Laval, Canada Clinical Trials

A listing of Laval, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

datscan
modafinil
methyldopa
resting tremor
parkinson's disease
McGill University
 (9.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +45 other locations
Cell-free DNA in Hereditary And High-Risk Malignancies

The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. …

cell-free dna
blood test
cancer
hereditary cancer syndromes
hereditary cancer
Jewish General Hospital
 (8.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
First Level Socio-geriatric Evaluation: ESOGER Databank

Coronavirus disease 2019 (COVID-19) is an infectious disease. Physical distancing is one of the most effective ways to reduce the spread of COVID-19, but this key prevention intervention may have adverse consequences on older adults living at home. Screening older adults living at home and at risk for adverse consequences …

coronavirus
covid-19
coronavirus infection
Jewish General Hospital
 (8.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population

Introduction: Second Generation Antipsychotics (SGAs) are widely used in the pediatric population. It is currently established that SGAs may induce undesirable metabolic adverse events (AEs) such as weight gain, metabolic changes in blood lipids or glucose with risk of potential cardiovascular morbidity and mortality. The Canadian Alliance for Monitoring Effectiveness …

blood test
hematology test
pediatric
Ben Amor Leila
 (8.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location